While Deckers stock has outshined the broader market over the past year, Wall Street analysts remain moderately optimistic about its prospects.
For Immediate ReleasesChicago, IL – November 29, 2024 – Zacks.com announces the list of stocks and featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news...
Cyber security companies’ near-term trends are mixed but lean toward a “more cautious” outlook, with commentaries pointing to large deal delays.
For Immediate ReleaseChicago, IL – November 29, 2024 – Stocks in this week’s article are Bilibili Inc. BILI, BrightSphere Investment Group Inc. BSIG and Orchid Island Capital, Inc. ORC.Top 3 Stocks...
Despite Simon Property significantly outperforming the broader market over the past year, Wall Street analysts remain moderately optimistic about the stock's growth prospects.
Retail sentiment on the stock turned 'bearish' (34/100) from 'neutral' (47/100).
KANZHUN LIMITED has repurchased over 6.2 million shares in November, totaling over RMB300 million, underscoring management's confidence.Quiver AI SummaryKANZHUN LIMITED, known as BOSS Zhipin, a leading...
Three Reasons Why KEX is Risky and One Stock to Buy Instead
Teva Pharmaceutical Industries Limited’s TEVA stock has declined 10% in a month despite strong third-quarter results announced earlier this month. The company beat estimates for earnings as well as sales....
HUTCHMED announces ORPATHYS® will remain on China's National Reimbursement Drug List following contract renewal with NHSA.Quiver AI SummaryHUTCHMED (China) Limited announced that ORPATHYS® (savolitinib)...